The difficulties, priorities and perspectives of tourism in Cuba are today in the limelight of the island's main press media, with a view to the end of 2023 and the beginning of 2024.
The work on the use of the PIVKA-II biomarker in Cuba for the early detection of liver carcinoma was presented at the National Imaging Conference ORIENTIMAGEN 2025 held by the end of February in the city of Holguín.
Read more Encouraging use of the PIVKA-II Biomarker in the detection of liver cancer in CubaMore than 1.6 million general education students in Cuba will begin the 2024-2024 school year by receiving basic resources required for a quality education despite economic limitations.
The health intervention to the population with the Abdala vaccine began this Monday in the municipality of Holguín, by people aged 60 and over who will receive three doses of the immunogen in a 0-14-28-day schedule.
Read more Holguín: Health intervention with Cuban vaccine Abdala beginsPage 285 of 463